Skip to main content
Prateek Mendiratta, MD, Oncology, Cleveland, OH

PrateekMendirattaMD

Oncology Cleveland, OH

Genitourinary Oncology, Hematologic Oncology

Assistant Professor in Hematology/Oncology

Dr. Mendiratta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mendiratta's full profile

Already have an account?

  • Office

    UH Cleveland Medical Center
    11100 Euclid Ave Department of Medicine-Hematology and Oncology
    Cleveland, OH 44106
    Phone+1 216-844-3951
    Fax+1 216-201-8160

Summary

  • Dr. Prateek Mendiratta is an Oncologist based in Cleveland, OH who specializes in Genitourinary and Hematologic Oncology. His education includes a Residency in Internal Medicine from the McGaw Medical Center of Northwestern University, a Fellowship in Hematology and Medical Oncology from Duke University Hospital, an experimental therapeutics fellowship from Cleveland Clinic Foundation, and a B.S. in Biology, Magna Cum Laude with Honors, from Virginia Commonwealth University. He holds several professional roles encompassing various facets of oncology and has significant experience with conditions such as hematologic oncology, squamous cell cancer of the bladder, adenocarcinoma of the prostate, hereditary prostate cancer, and urologic oncology. Dr. Mendiratta has published several scholarly articles in various respected scientific journals. His work has been recognized with a handful of awards, including the Patient Choice Award from Vitals and the ASCO Merit Award from the ASCO Annual Meeting.
  • Prateek Mendiratta

    ASCO Connection

    2318 Mill Road, Suite 800, Alexandria, VA 22314 | Phone 571-483-1300 | ©2018 American Society of Clinical Oncology (ASCO). All Rights Reserved Worldwide

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Experimental Therapuetics GU Fellow, 2017 - 2018
  • Duke University Hospital
    Duke University HospitalFellowship, Hematology and Medical Oncology, 2006 - 2009
  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2002 - 2005
  • Virginia Commonwealth University School of Medicine
    Virginia Commonwealth University School of MedicineClass of 2002
  • Virginia Commonwealth University
    Virginia Commonwealth UniversityB.S., Biology, Magna Cum Laude with Honors, 1994 - 1998

Certifications & Licensure

  • OH State Medical License
    OH State Medical License 2011 - 2026
  • NC State Medical License
    NC State Medical License 2005 - 2018
  • SC State Medical License
    SC State Medical License 2009 - 2011
  • IL State Medical License
    IL State Medical License 2002 - 2005
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Patient Choice Award Vitals, 2016
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • ASCO Merit Award ASCO Annual Meeting, 2008
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Treatment Selection for Men with Metastatic Prostate Cancer Who Progress on Upfront Chemo‐Hormonal Therapy  
    Vadim Koshkin, Prateek Mendiratta, Brian I Rini, Pedro Barata, Christos Kyriakopoulos, Hamid Emamekhoo, Timothy Gilligan, The Prostate
  • Genomic signatures associated with the Development, Progression, and Outcome of prostate cancer  
    Mendiratta P, Febbo, P, Molecular Diagnosis and therapy, 1/1/2007
  • Treatment of Hairy Cell Leukemia with 2-Chlorodexoyadenosine (2CdA): Long term follow-up of the Northwestern University Experience  
    Chadha P, Rademaker AW, Mendiratta P, et al, Blood, 1/1/2005

Books/Book Chapters

Abstracts/Posters

  • A Genomic Strategy for targeting therapy in Castrate-Independent Prostate Cancer
    Mendiratta P, ASCO, 1/1/2008

Lectures

  • Genomic Strategy for targeting therapy in Castrate-Independent Prostate Cancer 
    1/1/2009

Press Mentions

  • Inside Sean Parker's $250 Million Bet to Cure Cancer
    Inside Sean Parker's $250 Million Bet to Cure CancerApril 13th, 2016

Professional Memberships